Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubes

Biochemical Pharmacology

Volumn 62, Issue 7, 2001, Pages 893-902

  Cazzalini, Ornella ^a   Lazzè, Maria C ^a   Iamele, Luisa ^a   Stivala, Lucia A ^a   Bianchi, Livia ^a   Vaghi, Patrizia ^b   Cornaglia, Antonia ^b   Calligaro, Alberto ^b   Curti, Daniela ^c   Alessandrini, Andrea ^d   Prosperi, Ennio ^c   Vannini, Vanio ^a  

^a Sez Patologia Generalec Golgi   (Italy)

^b Sez Istologia e Embriologia Generale   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d INFM   (Italy)

Author keywords

Atomic force microscope; JC 1; Laser scanning confocal microscopy; MtDNA; Myotubes; Zidovudine

Indexed keywords

CARDIOLIPIN; MITOCHONDRIAL DNA; ZIDOVUDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL MEMBRANE; ATOMIC FORCE MICROSCOPY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GENE DELETION; LONG TERM CARE; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MORPHOLOGY; MUSCLE MITOCHONDRION; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; SOUTHERN BLOTTING;

ANIMALS; CELLS, CULTURED; DNA, MITOCHONDRIAL; HISTOCYTOCHEMISTRY; MALE; MEMBRANE POTENTIALS; MICROSCOPY, ATOMIC FORCE; MITOCHONDRIA; MUSCLE, SKELETAL; RATS; RATS, WISTAR; ZIDOVUDINE;

EID: 0035479892     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00713-4     Document Type: Article

References (40)

1. Factors determining the activity of 2′,3′-dideoxynucleosides in suppressing human immunodeficiency virus in vitro
2. Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC
3. Mitochondrial myopathy caused by long-term zidovudine therapy
4. Zidovudine-associated myopathy
5. Necrotising myopathy and zidovudine
6. Zidovudine-associated myopathy
7. Zidovudine induces molecular biochemical and ultrastructural changes in rat skeletal muscle mitochondria
8. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model
9. Zidovudine-induced experimental myopathy: Dual mechanism of mitochondrial damage
10. AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria
11. The effect of L-carnitine on the AZT-induced destruction of human myotubes. Part II: Treatment with L-carnitine improves the AZT-induced changes and prevents further destruction
12. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells
13. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
14. Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-deoxythymidine
15. The Friend murine erythroleukemia cell, a model system for studying the association between bone marrow toxicity induced by 3′-azido-3′-deoxythymidine and dideoxynucleoside inhibition of mtDNA replication
16. Massive conversion of guanosine to 8-hydroxyguanosine in mouse liver mitochondrial DNA by administration of azidothymidine
17. Cellular and mitochondrial toxicity of zidovudine (AZT), didosine (ddI) and zalcitabine (ddC) on cultured human muscle cells
18. AZT caused tissue-specific inhibition of mitochondrial bioenergetic function
19. Mitochondria as cell targets of AZT (zidovudine)
20. Zidovudine myopathy: A distinctive disorder associated with mitochondrial disfunction
21. Major growth and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine
22. Cell system for ex vivo studies of myogenesis: A protocol for the isolation of stable muscle cell population from newborn to adult mice
23. Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorimetric analysis at the single organelle level
24. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1
25. Mitochondrial membrane potential changes in osteoblasts treated with parathyroid hormone and estradiol
26. Subfractionation of mitochondria, and isolation of the proteins of oxidative phosphorylation
27. Assay of succinate deydrogenase activity by a colorimetric-continous method using iodonitrotetrazolium chloride as electron acceptor
28. Cytochrome oxidase from beef heart mitochondria
29. +-linked isocitrate dehydrogenase, glutamate dehydrogenase, aspartate aminotransferase and alanine aminotransferase in nervous tissues from vertebrates and invertebrates
30. Protein measurement with the Folin phenol reagent
31. A simplified method for the quantitative assay of small amounts of protein in biologic material
32. Fractured polymer/silica fiber surfaces studied by tapping mode atomic force microscopy
33. Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts
34. The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction
35. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage
36. 31P magnetic spectroscopy suggested impaired mitochondrial function in AZT-treated HIV-infected patients
37. Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy
38. The universality of bioenergetic disease and amelioration with redox therapy